Credit: PROFESSOR JOHN ZAJICEK/Science Source
And, importantly, view the impact of MS through the eyes of individual patients who generously tell their stories of how they build their lives around their abilities, not their disabilities.
The road to a cure for MS lies ahead. Along the way, clinicians, physicians, and patients are sharing their stories of working toward that goal at The Multiple Sclerosis Journey. We invite you to join them.
Walk with us.
Comorbidities are common in patients with multiple sclerosis (MS), can impact treatment decisions, and require a multidisciplinary approach to management, including careful attention to lifestyle issues, said Patricia Melville, RN, MSN, NP-C, MSCN, in a presentation at the virtual annual meeting of the Consortium of Multiple Sclerosis Centers (CMSC).
For individuals with multiple sclerosis the experience of aging appears to follow along one of two paths – some people feel their preexisting disability gives them an advantage in coping and tolerating age-related difficulties, while others feel more acutely the double burdens of MS and aging.
Mindfulness-based interventions such as day wellness programs have the potential to improve mood and overall emotional awareness in people with multiple sclerosis (MS), according to preliminary results of two small, early-phase studies presented at the 2020 virtual meeting of the Consortium of Multiple Sclerosis Centers.
About one in five patients with multiple sclerosis don’t know their clinical phenotype – information that may help inform long-term treatment options for their disease, according to research presented at the 2020 virtual annual meeting of the Consortium of Multiple Sclerosis Centers.
A number of emerging MRI measures with which to diagnose and stage multiple sclerosis (MS) are in development and nearly ready for expanded clinical use, according to a recent review article in the Multiple Sclerosis Journal